Recent Research | Page 19 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journal Bone Marrow Disease
Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment Sep 2016 Immunobiology paroxysmal nocturnal hemoglobinuria (PNH)
Eltrombopag for the treatment of aplastic anemia: current perspectives Sep 2016 Drug Des Devel Ther aplastic anemia
Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study Sep 2016 Int J Cancer myelodysplastic syndromes (MDS)
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation Sep 2016 J Clin Oncol myelodysplastic syndromes (MDS)
Diagnostic screening of paroxysmal nocturnal hemoglobinuria: Prospective multicentric evaluation of the current medical indications Sep 2016 Cytometry B Clin Cytom paroxysmal nocturnal hemoglobinuria (PNH)
Hematopoietic stem cell transplantation for acquired aplastic anemia Sep 2016 Curr Opin Hematol aplastic anemia
Hematopoietic Cell Transplantation for Myelodysplastic Syndromes Sep 2016 J Oncol Pract myelodysplastic syndromes (MDS)
Hematopoietic Stem Cell Regulation by Type I and II Interferons in the Pathogenesis of Acquired Aplastic Anemia Aug 2016 Front Immunol aplastic anemia
Assessing Quality of Care for the Myelodysplastic Syndromes Aug 2016 Curr Hematol Malig Rep myelodysplastic syndromes (MDS)
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)-ViLen-01 protocol Aug 2016 Ann Hematol myelodysplastic syndromes (MDS)